MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Reconstructing the history of Machado-Joseph disease

    A. Meira, J. Pedroso, F. Germiniani, O. Barsottini, H. Teive (São Paulo, Brazil)

    Objective: The authors debate if previous descriptions of cerebellar ataxias with autossomal dominant pattern of inheritance, resembling MJD phenotipically, should gain the merit of first…
  • 2019 International Congress

    Opsoclonus-Myoclonus-Ataxia Syndrome – Ljubljana University Children’s Hospital clinical series

    J. Orazem Mrak, D. Osredkar, D. Neubauer (Ljubljana, Slovenia)

    Objective: Analysis of number, clinical characteristics and outcome of patients admitted to our department due to OMS in the past 25 years. Background: Opsoclonus-myoclonus-ataxia syndrome…
  • 2019 International Congress

    The impact of non-motor symptoms on the quality of life of patients with Parkinson’s disease depending on its stages

    K. Abdurakhmonova, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: To study impact of non-motor symptoms evaluated with the Non-Motor Symptoms Scale (NMSS) and on Parkinson’s disease (PD) patients’ quality of life (QOL) depending…
  • 2019 International Congress

    (Not) sleeping with the enemy: Cognitive correlates of nocturnal sleep disturbances in Parkinson’s disease

    S. Castillo-Torres, C. Cerda-Contreras, D. Roque-Martínez, D. Díaz-Pérez, X. Ortiz-Jiménez, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

    Objective: To evaluate cognitive correlates of nocturnal sleep dysfunction in patients with idiopathic Parkinson’s disease (PD). Background: Sleep disturbances are among the most troublesome and…
  • 2019 International Congress

    Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease

    M. El Haddouchi, A. Handberg, K. Svaerke, A. Loekkegaard (Copenhagen, Denmark)

    Objective: To investigate whether response to dopaminergic medication (DM) correlates to inhibitory cognitive control (IC) in patients with Parkinson's disease (PD). Background: In the MDS…
  • 2019 International Congress

    Comparison of Zonisamide with Non-Levodopa, Anti-Parkinson’s disease Drugs in the Incidence of Parkinson’s Disease-Relevant Symptoms

    H. Iwaki, M. Tagawa, K. Iwasaki, K. Kawakami, M. Nomoto (Toon, Japan)

    Objective: This study was to compare zonisamide and other anti-PD drugs by analyzing their associations with the incidence of PD-relevant symptoms. Background: Patients with Parkinson’s…
  • 2019 International Congress

    Exploring the Lexicon of Fatigue in Parkinson Disease: A Qualitative Approach

    S. Mantri, S. Albert, S. Kahl, M. Daeschler, E. Mamikonyan, C. Kopil, C. Marras, L. Chahine (Durham, NC, USA)

    Objective: To understand how patients with Parkinson disease (PD) experience fatigue and identify potential communication barriers between doctors and patients. Background: Fatigue in PD is…
  • 2019 International Congress

    Tracking cortical changes throughout cognitive decline in Parkinson’s disease: a longitudinal MRI study

    E. Canu, F. Agosta, T. Stojković, S.. Basaia, I. Stankovic, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

    Objective: To investigate longitudinal cortical thinning (CT) in Parkinson’s disease (PD) patients with normal cognition (PD-CN), stable mild cognitive impairment (PD-MCIs), and patients who convert…
  • 2019 International Congress

    Neuroanatomical and Electrocortical Networks correlates in Parkinson’s Disease Patients with Mild Cognitive Impairment:The PaCoS Study

    G. Donzuso, G. Giuliano, R. Monastero, R. Baschi, G. Mostile, A. Luca, C. Cicero, M. Zappia, A. Nicoletti (Catania, Italy)

    Objective: Aim of the study is to evaluate the presence of grey matter (GM) and electrocortical changes in Pd patients with MCI. Background: Mild cognitive…
  • 2019 International Congress

    Imaging Brain Insulin Resistance in Parkinson’s Disease using [¹⁸F]FDG-PET

    E. Hogg, P. Linesch, T. Wu, E. Tan, Z. Fan, W. Gao, A. Waxman, M. Tagliati (Los Angeles, CA, USA)

    Objective: To obtain a glucose brain uptake survey of Parkinson's Disease (PD) patients with or without insulin resistance (IR). Background: IR is common in PD…
  • « Previous Page
  • 1
  • …
  • 79
  • 80
  • 81
  • 82
  • 83
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley